MedPath
FDA Approval

Ravicti

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 13, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

HAS Healthcare Advanced Synthesis SA

Horizon Therapeutics USA, Inc.

481296960

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ravicti

Product Details

NDC Product Code
75987-050
Application Number
NDA203284
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 13, 2021
Code: ZH6F1VCV7BClass: ACTIBQuantity: 1.1 g in 1 mL
© Copyright 2025. All Rights Reserved by MedPath